Correlation Between KB Financial and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both KB Financial and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KB Financial and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KB Financial Group and Akari Therapeutics PLC, you can compare the effects of market volatilities on KB Financial and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KB Financial with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of KB Financial and Akari Therapeutics.
Diversification Opportunities for KB Financial and Akari Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between KB Financial and Akari is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding KB Financial Group and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and KB Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KB Financial Group are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of KB Financial i.e., KB Financial and Akari Therapeutics go up and down completely randomly.
Pair Corralation between KB Financial and Akari Therapeutics
Allowing for the 90-day total investment horizon KB Financial Group is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, KB Financial Group is 5.1 times less risky than Akari Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 100.00 in Akari Therapeutics PLC on December 30, 2024 and sell it today you would earn a total of 27.00 from holding Akari Therapeutics PLC or generate 27.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
KB Financial Group vs. Akari Therapeutics PLC
Performance |
Timeline |
KB Financial Group |
Akari Therapeutics PLC |
KB Financial and Akari Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with KB Financial and Akari Therapeutics
The main advantage of trading using opposite KB Financial and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KB Financial position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.KB Financial vs. Shinhan Financial Group | KB Financial vs. Woori Financial Group | KB Financial vs. Korea Electric Power | KB Financial vs. Orix Corp Ads |
Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |